Delivery Order SPE2DB22D3016-SPE2DB25FAHR2

Award Date 12/30/24
Potential Completion Date 1/22/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,325.64 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 gram/100 ml vials and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400 ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,876.40, is a Firm Fixed Price Delivery Order for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,109.55 firm fixed-price delivery order contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, a specialty medication, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $59,703.36, is for the delivery of GAMUNEX-C 40 gram/400 ml vials. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,950.56 firm fixed price delivery order covers the supply of GAMUNEX-C 40 gram/400 ml vials, with an ultimate completion date of December 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of GAMUNEX-C 40 gram/400 ml vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $29,851.68 and a performance period through January 17, 2025. AmerisourceBergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,366.76 firm fixed-price delivery order is for the supply of GAMUNEX-C 20 gram/200 ml vials, a critical medical product. The contract has a period of performance through December 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract, valued at $4,809.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Department of Defense (DoD) agency, and has a completion date of July 2, 2024. The contract is a Delivery Order on a Firm Fixed Price basis, with no set-aside designation. AmerisourceBergen holds a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAHR2
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,851.68, is for the delivery of GAMUNEX-C 40 gram/400 ml vials. This is a firm fixed-price delivery order contract with a period of performance ending on January 22, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award was not designated with a set-aside requirement, indicating open competition.

Generated 3/31/25, 9:33 AM